Australia Rejects Bid to Reschedule Psilocybin, MDMA for Therapeutic Use
Policy
Mind Medicine Australia, a psychedelics advocacy organization that filed the application, says the country "lost a massive opportunity to be a leader in this field with this decision.”
Leave a Reply
Want to join the discussion?Feel free to contribute!